OnabotulinumtoxinA Is Efficacious and Well Tolerated in Male Patients With Overactive Bladder and Urinary Incontinence: Placebo-Controlled Treatment Cycle 1 Results From a Pooled Analysis of Four Randomized Trials. (July 2022) - Nitti, V.; Ginsberg, D.A.; Kohan, A.; McCammon, K.; Jenkins, B.; Yushmanova, I.; Boroujerdi, A.; Chapple, C.